St. Larsen et al., Di-(2-ethylhexyl) phthalate possesses an adjuvant effect in a subcutaneousinjection model with BALB/c mice, TOX LETT, 125(1-3), 2001, pp. 11-18
The prevalence of allergic airway diseases is rapidly increasing in Western
Europe and North America and the introduction of anthropogenic chemicals m
ay explain a part of this increase. Recently, our group found that degradat
ion products from several commonly used phthalate plasticizers possess adju
vant activity in an animal model. Mono-2-ethylhexyl phthalate, which is the
degradation product of di-(2-ethylhexyl) phthalate (DEHP), was among these
substances. These findings prompted the study of the adjuvant activity of
the parent compound itself. Thus, DEHP was studied in a model using ovalbum
in (OA) as the model antigen. OA was injected subcutaneously in the neck re
gion of BALB/cJ mice with or without DEHP. The levels of OA-specific IgE, I
gG1 and IgG2a antibodies in sera were measured by ELISA. Adjuvant effect, d
efined as a statistically significant increase in antibody level, was obser
ved with IgG1 at a concentration of 2000 mug DEHP/ml after both one and two
boosters. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.